WallStSmart

Coca-Cola European Partners PLC (CCEP)vsPhilip Morris International Inc (PM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Philip Morris International Inc generates 99% more annual revenue ($41.49B vs $20.90B). PM leads profitability with a 26.7% profit margin vs 9.3%. PM appears more attractively valued with a PEG of 2.62. PM earns a higher WallStSmart Score of 52/100 (C-).

CCEP

Buy

52

out of 100

Grade: C-

Growth: 6.7Profit: 7.0Value: 4.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.59

PM

Buy

52

out of 100

Grade: C-

Growth: 4.7Profit: 8.5Value: 3.3Quality: 6.5
Piotroski: 4/9Altman Z: 2.02
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CCEP.

PMSignificantly Overvalued (-79.3%)

Margin of Safety

-79.3%

Fair Value

$110.70

Current Price

$200.17

$89.47 premium

UndervaluedFair: $110.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP3 strengths · Avg: 9.3/10
Return on EquityProfitability
42.9%10/10

Every $100 of equity generates 43 in profit

EPS GrowthGrowth
68.3%10/10

Earnings expanding 68.3% YoY

Free Cash FlowQuality
$1.51B8/10

Generating 1.5B in free cash flow

PM5 strengths · Avg: 9.4/10
Market CapQuality
$302.83B10/10

Mega-cap, among the largest globally

Operating MarginProfitability
36.0%10/10

Strong operational efficiency at 36.0%

Debt/EquityHealth
-5.7210/10

Conservative balance sheet, low leverage

Profit MarginProfitability
26.7%9/10

Keeps 27 of every $100 in revenue as profit

Free Cash FlowQuality
$5.11B8/10

Generating 5.1B in free cash flow

Areas to Watch

CCEP4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.2%4/10

0.2% revenue growth

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Debt/EquityHealth
1.363/10

Elevated debt levels

PEG RatioValuation
3.182/10

Expensive relative to growth rate

PM4 concerns · Avg: 2.8/10
P/E RatioValuation
26.5x4/10

Moderate valuation

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

PEG RatioValuation
2.622/10

Expensive relative to growth rate

EPS GrowthGrowth
-9.3%2/10

Earnings declined 9.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on Return on Equity, EPS Growth, Free Cash Flow.

Bull Case : PM

The strongest argument for PM centers on Market Cap, Operating Margin, Debt/Equity. Profitability is solid with margins at 26.7% and operating margin at 36.0%.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : PM

The primary concerns for PM are P/E Ratio, Return on Equity, PEG Ratio.

Key Dynamics to Monitor

CCEP profiles as a value stock while PM is a mature play — different risk/reward profiles.

CCEP carries more volatility with a beta of 0.47 — expect wider price swings.

PM is growing revenue faster at 9.1% — sustainability is the question.

PM generates stronger free cash flow (5.1B), providing more financial flexibility.

Bottom Line

CCEP scores higher overall (52/100 vs 52/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Philip Morris International Inc

CONSUMER DEFENSIVE · TOBACCO · USA

Philip Morris International Inc. (PMI) is a Swiss-American multinational cigarette and tobacco manufacturing company, with products sold in over 180 countries. The most recognized and best selling product of the company is Marlboro.

Want to dig deeper into these stocks?